WHO ICTRP trial
An open-label, escalating dose, proof of concept study to determine the effects…
ISRCTN81647490 · International Standard Randomised Controlled Trial Number (ISRCTN) · Not Recruiting
Key facts
| Trial ID | ISRCTN81647490 |
|---|---|
| Public title | An open-label, escalating dose, proof of concept study to determine the effects of single oral doses of PSD506 on unstable urinary bladder contractions induced by volume provocation in subjects with detrusor hyper-reflexia secondary to spinal injuries above T12 |
| Scientific title | An open-label, escalating dose, proof of concept study to determine the effects of single oral doses of PSD506 on unstable urinary bladder contractions induced by volume provocation in subjects with detrusor hyper-reflexia secondary to spinal injuries above T12 |
| Primary sponsor | Plethora Solutions Ltd (UK) |
| Registry | International Standard Randomised Controlled Trial Number (ISRCTN) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Phase | Not Specified |
| Countries | United Kingdom |
| Conditions | Detrusor hyper-reflexia secondary to spinal injury (mid-thoracic or cervical level) Urological and Genital Diseases Detrusor hyper-reflexia |
| Interventions | Single oral administration of PSD506 capsules 5 mg to 40 mg |
| Registration date | Apr 20, 2007 |
| Target size | 18 |
| Secondary IDs | PSD506-OAB-002 |
| Registry page | isrctn.com |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: